Pharmaceutical companies’ relationships with thought leaders have changed in light of regulations that aim to address conflicts of interest. But these individuals still are trusted advisors who can help pharma reach physicians.
Thought leaders — scientific and clinical experts — play a pivotal role in helping pharma companies identify key topics of interest to physicians. Depending on their role, these KOLs provide launch and sales support or play a critical role in continuing medical education. They provide solid, evidenced-based education that translates science into practical application and informs their colleagues about new, cutting-edge information.
The relationship between pharma companies and thought leaders is changing in light of regulations that aim to address conflicts of interest, and industry experts say there is a need for strategic planning when reaching out to these experts…
Experts on this Topic
Charlie Buckwell. CEO, Complete Medical Group, Cheshire, United Kingdom; Complete Medical Group is the medical education and medical communications specialist group within McCann Healthcare Worldwide. For more information, visit complete-grp.com.
Jon Easter. Director, Pharmaceutical Research, Best Practices LLC, Chapel Hill, N.C.; Best Practices is a research, consulting, and publishing firm. For more information, visit best-in-class.com.
Charles Isaac. CEO and Founder, Skychaser Communications Inc., New York; Skychaser is a global digital-solutions and consulting company that develops and markets Primedicine, a hosted continuing medical education product. For more information, visit skychaseronline.com.
Heidi L. Liston, Pharm.D. Senior VP and General Manager, DiMedix LLC, Warren, N.J.; DiMedix is a full-service medical-education company. For more information, visit dimedix.com.
Jim Melton. CEO, PMPN, Durham, N.C.; PMPN manages medical-education programs through a network of meeting managers. For more information, visit pmpn.com.
Marsha Meyer. Senior VP of Clinical Information, CME LLC, Irvine, Calif.; CME provides high-quality lifelong learning opportunities for clinicians. For more information, visit cmellc.com.
Mario R. Nacinovich Jr. Senior VP, Fission Communications, New York; Fission is a full-service, global medical-education company. For more information, visit fissioncommunications.com.
Robert Nauman. Principal, BioPharma Advisors Network, Cary, N.C.; BioPharma Advisors Network is a community of consultants who collaborate on ideas to maximize the impact of their advice on clients’ businesses. For more information, visit biopharmaadvisors.net.
Gary Schwebach, Ph.D. Founding Principal, G & S Research Inc., Carmel, Ind.; G & S Research provides primary market-research services to pharmaceutical, biotech, medical device, and diagnostics firms worldwide. For more information, visit gs-research.com.
Lawrence Sherman. CEO, The Physicians Academy for Clinical and Management Excellence, New York; The Physicians Academy partners with leading academic institutions to offer a comprehensive portfolio of educational programs for physicians. For more information, visit physiciansacademy.com.
Robin L. Winter-Sperry, M.D. President and CEO, Scientific Advantage LLC, Bernardsville, N.J.; Scientific Advantage is an integrated company that specializes in the development of medical science liaison (MSL) divisions. For more information, visit scientificadvantage.com.
Deborah Wood. President and CEO, Deborah Wood Associates and CME Enterprise Inc., Carmel, Ind.; CME Enterprise, the continuing medical-education subsidiary of Deborah Wood Associates, develops extensive needs assessments, executes needs-based curricula, and impacts practitioner knowledge and patient outcomes. For more information, visit cmeenterprise.com.